|
|
Basilea Pharmaceutica Limited - Comparative Business Analysis Snapshot
Business Description
Basilea Pharmaceutica Limited. The Group's principal activity is to discover and develop drugs for the treatment of bacterial infections, fungal infections and skin diseases associated with high unmet medical needs. The Group focuses on antibacterial, antifungal and dermatological markets. The Group operates in Switzerland, China and Other Countries.
Competitor Analysis
This analysis compares Basilea Pharmaceutica Limited with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
